Cancers in Patients with Endometriosis

In: Geburtshilfe und Frauenheilkunde · 2018 · doi:10.1055/s-0038-1675455 · W2907233873
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-10

This study aimed to determine the frequencies of various cancers occurring alongside endometriosis, a disease known to increase the risk of certain ovarian cancers.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-10 · read from full text

This retrospective study used the International Endometriosis Evaluation Program (IEEP) to characterize the frequencies of cancer diagnoses recorded as comorbidities among 4,539 endometriosis patients (after exclusions for missing surgical diagnosis, lesion location, or comorbidity documentation). Cancer prevalence was 2.4% overall, with the highest documented prevalence in patients with peritoneal endometriosis paired with adenomyosis (3.2%); endometrial cancer cases were concentrated in the adenomyosis group (4 of 5), and most ovarian cancer cases occurred among patients with ovarian endometriosis. The authors note a key limitation that the number of patients with cancer was small, leaving uncertainty despite observed differences between lesion/location groups. This paper is centrally about endometriosis — and specifically compares cancer comorbidity frequencies across endometriosis lesion types including adenomyosis-only, using IEEP registry data.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

It is known that endometriosis is associated with an increased risk for certain forms of ovarian cancer. However it is unknown, which kind of endometriosis is associated with ovarian cancer and furthermore, if endometriosis is associated with the risk for other cancers than ovarian cancer. However similar to other diseases endometriosis is a heterogeneous disease having different effects on pain or fertility as well as endometriosis is located in several locations like peritoneum, ovaries, uterus and might even infiltrate adjacent organs. Aim of this study was to describe the freuqencies of cancers as co-morbidities in a population of endometriosis patients.
Full text 2,684 characters · extracted from oa-doi-fallback · 5 sections · click to expand

Acknowledgement

The AGO-TraFo is grateful to the German Cancer Society (Deutsche Krebsgesellschaft e.V.) for their financial support of the 10th scientific symposium of the AGO-TraFo. Publication History Publication Date: 26 November 2018 (online)

Background

It is known that endometriosis is associated with an increased risk for certain forms of ovarian cancer. However it is unknown, which kind of endometriosis is associated with ovarian cancer and furthermore, if endometriosis is associated with the risk for other cancers than ovarian cancer. However similar to other diseases endometriosis is a heterogeneous disease having different effects on pain or fertility as well as endometriosis is located in several locations like peritoneum, ovaries, uterus and might even infiltrate adjacent organs. Aim of this study was to describe the freuqencies of cancers as co-morbidities in a population of endometriosis patients.

Material and methods

Within the International Endometriosis Evaluation Program (IEEP) a total of over 9523 patients have been documented beween February 2014 and July 2018. For this retrospective analysis patients had to be excluded without a documented surgical diagnosis of endometriosis. Further 560 patietns wer excluded without exact documentation of the location of the endometriosis lesion. No documentation of co-morbidities was done in 1697 patients resulting in the exclusion of those patients. Therefore the final study population consisted of 4539 endometriosis patients. Cancer diagnosis frequencies were calculated for the following 5 groups. Group 1: peritoneal endometriosis, group 2: peritoneal endometriosis and adenomyosis, group 3: adenomyosis only, group 4: peritoneal endometriosis and deep infiltrating endometriosis, group 5: ovarian endometriosis.

Results

With regard to the 4539 pateints, in 107 cases (2.4%) a malignant disease was documented. In patietns from group 2 the cancer prevalence was highest with 3.2% and 0.9% in the group of patients with deep infiltrating endometriosis. Interestingly of 5 endometrial cancers 4 were diagnosed in patients with adenomyosis and 2 of 3 ovarian cancers in the group of patients with ovarian endometriosis.

Conclusion

This study is one of the first to analyze cancer prevalence in a group of endometriosis patients. There is some evidence, that cancer might be more prevalent in the group of patients with peritoneal endometriosis paired with adenomyosis. However sample sizes of patients diseased with cancer is small. Therefore larger registries are needed to adress this question further.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0 · commercial use OK